EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Association Between Pre‐Diagnostic Delay and Survival Among Patients With Esophageal and Gastric Cancer Treated With Curative Intent During the COVID19 Pandemic

Xin Wang iD, Yvonne Bach iD, Katherine Lajkosz, Osvaldo Espin-Garcia, Hiroko Aoyama, Michael Wang, Ronan McLaughlin, Lucy Ma iD, Carly Barron, Farooq Abdul Rehman iD, Eric Xueyu Chen, Johnathan Chi-Wai Yeung und 9 weitere

Cancer Medicine · 2025

DOI: 10.1002/cam4.70939 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2025. Verfasst von Xin Wang und 20 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medical Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Esophageal Neoplasms, COVID-19, Stomach Neoplasms, Delayed Diagnosis. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The majority of esophageal and gastric cancers are diagnosed at an advanced stage with poor overall survival (OS). Whether the pre‐diagnostic interval from symptom onset has any impact on OS is unclear. We investigated this question in the peri‐COVID19 pandemic era.

Methods

We retrospectively analyzed a cohort of 308 patients with esophageal, gastroesophageal junction, or gastric carcinoma treated with curative intent at the Princess Margaret Cancer Centre from January 2017 to December 2021. Clinical details pertaining to the initial presentation were determined through a retrospective chart review. Cox proportional hazards regression models were used to assess the association between pre‐diagnostic intervals and OS, adjusting for baseline patient characteristics.

Results

The median interval from symptom onset to diagnosis was 98 days (IQR 47–169 days). Using a cox proportional hazard model, prolonged pre‐diagnostic interval was not associated with worse OS (HR 1.00, p = 0.62). Comparing patients diagnosed before and during the COVID19 pandemic, there was a notable increase in diagnostic delay with median pre‐diagnostic interval increasing from 92 to 126 days ( p = 0.007). Median age at time of diagnosis was 69.6 during the pandemic vs. 64.7 before the pandemic. Linear regression showed squamous cell histology was significantly associated with increasing time to initial diagnosis ( p = 0.04), but this did not hold true in a multivariable model. Looking at other delay metrics, there were no changes in time interval from diagnosis to treatment during versus before the pandemic (median = 1.7 weeks for both), and there was no change in time from diagnosis to resection in those patients who underwent surgery.

Conclusion

The COVID19 pandemic caused significant diagnostic delay for patients presenting with curative gastroesophageal and gastric cancer. The lack of correlation of pre‐diagnostic interval with OS may reflect underlying tumor biology as the driving force that determines prognosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Esophageal NeoplasmsCOVID-19Stomach NeoplasmsDelayed DiagnosisHumansMaleFemaleAgedRetrospective StudiesMiddle AgedSARS-CoV-2Proportional Hazards ModelsPrognosis

Stichwörter der Autor:innen

COVID19diagnosisgastric cancergastroesophageal cancer

Autor:innen und Institutionen

  • Division of Medical Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Eliot Phillipson Clinician-Scientist Training Program, University of Toronto, Toronto, Ontario, Canada.
  • Department of Biostatistics, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Epidemiology and Biostatistics, Schulich School of Medicine and Dentistry, London, Ontario, Canada.
  • Department of Bio-Medical Science, Guelph University, Guelph, Ontario, Canada.
  • Division of Thoracic Surgery, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada.

ORCID-Profile: Xin Wang, Yvonne Bach, Lucy Ma, Farooq Abdul Rehman

Zitieren

APA

Wang, X., Bach, Y., Lajkosz, K., Espin-Garcia, O., Aoyama, H., Wang, M., McLaughlin, R., Ma, L., Barron, C., Rehman, F. A., Chen, E. X., Yeung, J. C., Swallow, C. J., Brar, S., Wong, R., Mesci, A., Kim, J., Veit-Haibach, P., Kalimuthu, S., …, & Elimova, E. (2025). Association Between Pre‐Diagnostic Delay and Survival Among Patients With Esophageal and Gastric Cancer Treated With Curative Intent During the COVID19 Pandemic. Cancer Medicine. https://doi.org/10.1002/cam4.70939

Vancouver

Wang X, Bach Y, Lajkosz K, Espin-Garcia O, Aoyama H, Wang M, et al. Association Between Pre‐Diagnostic Delay and Survival Among Patients With Esophageal and Gastric Cancer Treated With Curative Intent During the COVID19 Pandemic. Cancer Medicine. 2025. doi:10.1002/cam4.70939

BibTeX
@article{Wang2025,
  author = {Wang, Xin and Bach, Yvonne and Lajkosz, Katherine and Espin-Garcia, Osvaldo and Aoyama, Hiroko and Wang, Michael and McLaughlin, Ronan and Ma, Lucy and Barron, Carly and Rehman, Farooq Abdul and Chen, Eric Xueyu and Yeung, Johnathan Chi-Wai and Swallow, Carol J and Brar, Savtaj and Wong, Rebecca and Mesci, Aruz and Kim, John and Veit-Haibach, Patrick and Kalimuthu, Sangeetha and Jang, Raymond Woo-Jun and Elimova, Elena},
  title = {Association Between Pre‐Diagnostic Delay and Survival Among Patients With Esophageal and Gastric Cancer Treated With Curative Intent During the COVID19 Pandemic},
  journal = {Cancer Medicine},
  year = {2025},
  doi = {10.1002/cam4.70939}
}
Kostenlos starten →